Q4H4E9 AF NFT

Ribostamycin:4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoyl-[BtrI acyl-carrier protein] 4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoate transferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib6guhh7w5y6zszwzhb244uuu42bn42dravyc4pni3yap37y4ydsy/metadata.json
IPFS of structure file: 
bafybeidtdhpuplkt2uumong552y7u4aq4m6cnihujmp45kd7laewrmhcde/AF-Q4H4E9-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xdaDB63a95Be33E56c74F2E7818063cE870cB856c
First NFT owner address (bech32): 
genesis1mtdk822muvl9d3609eupsp3uapcvhptvp4ku27
Current NFT ID #46924 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
46924
Accession (UniProt):
Q4H4E9
Name::
Ribostamycin:4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoyl-[BtrI acyl-carrier protein] 4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoate transferase
Experimental Method:
Predicted structure
Sequence source:
Niallia circulans

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q4H4E9 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q4H4E9|BTRH_NIACI Ribostamycin:4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoyl-[BtrI acyl-carrier protein] 4-(gamma-L-glutamylamino)-(S)-2-hydroxybutanoate transferase OS=Niallia circulans OX=1397 GN=btrH PE=1 SV=1 MCLTRYDEKFFDCRKSQIIAYLDSQQVPVIPLFYNSYQSTAEIYRQIFIENKSKWKYSEPSFSDDDLLRKGIRPVRASFPDFSQASDCLKDLLARHKLVFVWGDEYCLPYRKEAFQAIHSTHSLVVTGYDGENKAYYVEDWDGLYGYLPAVHLEAAFDSLSRQMRTLLVLELNDEEMRENKQEDTDLFRKWLQAFEDDYIFYDRVLLDMRDYEENRLISMDHGLRLIAASRHVFSKFLHYIDDAPEEVGLLIRNHQLANHIAAIVRRYIIAKQIDWDGAACKIRQLREQEDDFMRKLKSRYG